Transient Ischemic Attack
Also known as: Trasient ischemic attack / TIA / Transient Ischemic Attack (TIA) / Transient Ischaemic Attack / Ischemic Attack, Transient / Transient ischemic attacks / Transient ischaemic attacks / Transient cerebral ischemic attack, unspecified / Transient ischemic attacks (disorder) / Transient cerebral ischaemia NOS / Transient ischemic attack (disorder) / Transient cerebral ischemia (disorder) [Ambiguous] / (Transient ischaemic attacks) or (vertebro-basilar insufficiency) or (drop attacks) / (Drop attack) or (transient cerebral ischaemia) or (vertebro-basilar insufficiency)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01418 | Acenocoumarol | An anticoagulant drug used in the prevention of thromboembolic diseases in infarction and transient ischemic attacks, as well as management of deep vein thrombosis and myocardial infarction. |
| DB00945 | Acetylsalicylic acid | A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events. |
| DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB00975 | Dipyridamole | A phosphodiesterase inhibitor used to prevent postoperative thromboembolic events. |
| DB00145 | Glycine | An amino acid commonly used as a component of total parenteral nutrition and is also used as irrigation during surgery. |
| DB00699 | Nicergoline | An ergot derivative use for the treatment of symptoms associated with cerebrovascular abnormalities. |
| DB00175 | Pravastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and to reduce the risk of cardiovascular events, including myocardial infarction and stroke. |
| DB08816 | Ticagrelor | A P2Y12 platelet inhibitor used in patients with a history of myocardial infarction or with acute coronary syndrome (ACS) to prevent future myocardial infarction, stroke and cardiovascular death. |
| DB00682 | Warfarin | A vitamin K antagonist used to treat venous thromboembolism, pulmonary embolism, thromboembolism with atrial fibrillation, thromboembolism with cardiac valve replacement, and thromboembolic events post myocardial infarction. |